Towa Pharmaceutical Co., Ltd. (TYO: 4553)
Japan
· Delayed Price · Currency is JPY
3,220.00
-60.00 (-1.83%)
Jan 15, 2025, 3:45 PM JST
Towa Pharmaceutical Company Description
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.
The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products.
It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products.
The company was founded in 1951 and is headquartered in Osaka, Japan.
Towa Pharmaceutical Co., Ltd.
Country | Japan |
Founded | 1951 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 4,588 |
CEO | Itsuro Yoshida |
Contact Details
Address: 2-11, Shinbashi-cho Osaka, 571-8580 Japan | |
Phone | 81 6 6900 9100 |
Website | towayakuhin.co.jp |
Stock Details
Ticker Symbol | 4553 |
Exchange | Tokyo Stock Exchange |
Stock Type | Common Stock |
Fiscal Year | April - March |
Reporting Currency | JPY |
ISIN Number | JP3623150004 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Itsuro Yoshida | Chief Executive Officer |
Shiro Hatagami | Chief Financial Officer |